4

OWNERSHIP DOCUMENT

Company: BRAINSTORM CELL THERAPEUTICS INC.
Filed: July 26, 2019
Period of Report: July 26, 2019
Accession Number: 0001144204-19-036266

View Document ↗ View on SEC.gov ↗